NEWSROOM

Stock Index

PRISM Q&A CORNER – Ashlee Vogenthaler , Markets Editor, PRISM MarketView

PRISM Q&A CORNER – Ashlee Vogenthaler , Markets Editor, PRISM MarketView

Decoding Market Dynamics: An Interview with Ashlee Vogenthaler, PRISM MarketView’s Markets Editor New York, May 01, 2024 - At PRISM MarketView we are proud to feature Ashlee Vogenthaler as our Markets Editor. Ashlee combines a deep understanding of finance and economics with a passion for writing, offering our readers insightful analyses and engaging commentary. Influenced early on by her mother’s finance career and an inspiring high school class, Ashlee developed a keen interest in the stock...

read more
PRISM MarketView – Weekly Market Report – April 26, 2024 

PRISM MarketView – Weekly Market Report – April 26, 2024 

PRISM Market Pulse: Equities Rally Amid Mixed Big Tech Earnings; Economic Shifts and Sector-Specific Highlights New York, N.Y., April 26, 2024 - PRISM MarketView - Equities were higher through the morning into midday trading as the S&P 500 and Nasdaq are set to snap their three- and four-week losing streaks. Big tech was the topic of Street-talk this week as some of the Magnificent Seven reported earnings. The reports produced mixed and opposite reactions by the Street as Tesla (TSLA)...

read more
PRISM MarketView – Biotech Breakfast 

PRISM MarketView – Biotech Breakfast 

Roche’s Alecensa Gets FDA Green Light; ImmunityBio Gains as PDUFA Date Approaches for Bladder Cancer Drug; Key Drug Trial Failures in 2024 New York, N.Y., April 22, 2024 - PRISM MarketView - Healthcare equities finished mostly higher after a very quiet trading session on Friday. The S&P 500 Healthcare Index closed up +0.32% versus the S&P 500 Index which lost (0.88%) and the XBI settled down (0.78%). A lack of momentum today left Roche stock up by just +0.95% following the FDA greenlit...

read more
PRISM MarketView – Weekly Market Report 

PRISM MarketView – Weekly Market Report 

PRISM Market Pulse: Market Tumbles Amid Fed's Rate Stance; Mixed Corporate Earnings Highlight Sector Struggles New York, N.Y., April 19, 2024 - PRISM MarketView - Equities were down in the morning and into midday as the major indices remain on track to notch their third straight week of declines. Fedspeak continues to support the “higher-for-longer” narrative with no urgency to cut rates which has created further sharp outflows and investor skepticism. The Street has taken investors’ pulses in...

read more
PRISM MarketView – Bio Investor Alert

PRISM MarketView – Bio Investor Alert

New York, N.Y., April 18, 2024 - PRISM MarketView - More than 83,000 new cases of bladder cancer are diagnosed in the US each year, and the illness is responsible for around 17,000 deaths annually. Urothelial carcinoma accounts for 90% of bladder cancers in the US and western Europe, and surgery, followed by chemotherapy or radiation is the current standard of care. There are 24 drugs approved by the FDA for bladder cancer, but due to invasive and life-changing surgical procedures, researchers...

read more
PRISM MarketView – Biotech Breakfast

PRISM MarketView – Biotech Breakfast

Mobile-Health Network Solutions (MNDR) IPOs; Q32 Bio Surges; EMA Concludes GLP-1 Drugs Not Associated with Suicidal Thoughts New York, N.Y., April 15, 2024 - PRISM MarketView - Healthcare equities finished lower on Friday, in line with broad declines across the market. The S&P 500 Healthcare Index closed down (1.52%) versus the S&P 500 Index which lost (1.46%) and the XBI settled down (3.43%). The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee concluded...

read more
PRISM MarketView Features Auto Parts 4 Less in the Automotive E-Commerce Marketplace

PRISM MarketView Features Auto Parts 4 Less in the Automotive E-Commerce Marketplace

New York, N.Y., April 05, 2024 - PRISM MarketView announces the release of an informative interview with Auto Parts 4 Less CEO Christopher Davenport, explaining the company’s strategic business model and focus on expanding its automotive eCommerce marketplace. Christopher Davenport - CEO of Auto Parts 4 Less Auto Parts 4 Less is an innovator focused on developing a world-class eCommerce marketplace for automotive parts that utilizes integrated technologies to optimize the listing, selling, and...

read more
PRISM MarketView – Biotech Breakfast

PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024

New York, N.Y., March 25, 2024 - PRISM MarketView - Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease areas. It takes 12 years on average for a company to take a drug from discovery to commercialization, and every hard-won FDA approval is a cause for celebration for researchers, companies and the end-users whose lives may be changed by these treatments. The past few...

read more
PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval

New York, N.Y., March 18, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights the FDA’s landmark approval of Rezdiffra™ and the companies leading the charge in developing new, safe, and effective treatments for liver disease. The landmark decision has shone a light on metabolic dysfunction-associated steatohepatitis (MASH), formerly known as non-alcoholic fatty liver disease, a leading cause of liver-related mortality that affects between...

read more
PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease

New York, N.Y., March 07, 2024 - PRISM MarketView announces the release of an insightful interview with Lipella Pharmaceuticals’ CEO, Dr. Jonathan Kaufman, discussing the company's recent regulatory accomplishments and how investors stand to benefit. Lipella Pharmaceuticals was recently granted Orphan Drug Designation by the FDA for LP-410, its drug candidate for oral Graft-versus-Host Disease (GvHD) and previously received Orphan Drug Designation for LP-10 in 2023. With these nods from the...

read more
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day

PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day

New York, N.Y., February 29, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, recognizes the remarkable contributions of companies developing treatments for the 10,000 rare diseases affecting more than 30 million Americans. All areas of medicine, and all organs and body systems, are impacted by rare diseases, including rare neurological and neuromuscular diseases, metabolic, skin and bone diseases, and chromosomal disorders. Approximately 95% of rare...

read more
PRISM MarketView Launches Emerging Consumer Products Index

PRISM MarketView Launches Emerging Consumer Products Index

Emerging companies harness advanced tech to innovate, launch new products, and adapt to inflation in consumer markets New York, N.Y., February 27, 2024 - PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging Consumer Products Index. As technologies advance, new innovative products are continuously being developed by emerging companies. These companies play a pivotal role in driving market dynamics and...

read more
Exploring Small-Cap AI Opportunities in a Big-Cap Dominated Market

Exploring Small-Cap AI Opportunities in a Big-Cap Dominated Market

New York, N.Y., January 24, 2024 - The recent rally in artificial intelligence (AI) investments had a notable exception: small caps. The Street’s James “Rev Shark” DePorre noted the stark contrast between the current AI bubble and the more inclusive Internet bubble of the late 1990s in his column “There is an AI Bubble, but There is No Small-Cap Participation.” He wrote, “During the Internet bubble in 1999-2000…hundreds of small-caps attracted speculative traders and helped drive the...

read more
PRISM Oil & Gas: S&P Sets Fresh YTD High; Falling Gasoline Prices Play Key Role in Cooling Inflation

PRISM Oil & Gas: S&P Sets Fresh YTD High; Falling Gasoline Prices Play Key Role in Cooling Inflation

NEW YORK, NY, December 13, 2023 - US equities closed mostly higher on Tuesday as the S&P set a fresh year-to-date high, finishing the day at its highest level since January 2022, just 3.2% below its all-time high. Energy stocks underperformed while gasoline prices were down (6%) for the month, playing a key role in cooling inflation numbers for November. The S&P 500 Energy Index was down (1.35%) versus the S&P 500 which rose +0.14%. The XLE settled down (1.39%), the XOP fell...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

NEW YORK, NY, December 12, 2023 - An immersive technology platform company, Glimpse recently announced its plans for a strategic shift from current immersive technologies that include virtual-reality headsets, tablets and phones to spatial computing, cloud and AI-driven immersive software solutions. From cutting-edge software development to immersive content creation, Glimpse pushes the boundaries of what is possible in the realm of extended realities....

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM MarketView Launches Emerging AdTech and Media Index

Leading global companies work to strike balance between digital and traditional advertising Industry experts point to 2H 2024 for AdTech and Media IPO market to strengthen NEW YORK, NY, December 12, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AdTech and Media Index. With a finger on the pulse of the digital media revolution, the PRISM index is tracking emerging companies making a mark on the adtech...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

Federal Reserve “Increasingly Confident” Policy Positioned to Slow Economy, Reduce Inflation; WTI and Brent Rebound from Morning Lows

NEW YORK, NY, November 28, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, today provides its PRISM Emerging Oil & Gas overview. US equities were narrowly mixed in Tuesday afternoon trading as November consumer confidence increased to 102 on the index, ahead of economists’ expectations. The S&P 500 Energy Index was up +0.85% versus the S&P 500 which rose +0.33%. The XLE settled at +0.82% while the XOP rose by +0.77%. The day’s PRISM Oil...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM MarketView Spotlights Significant Market Opportunities in Global Health with Launch of Emerging Public Health Index

NEW YORK, NY, November 14, 2023 - PRISM MarketView, a leader within the financial markets and news community, has debuted its PRISM Emerging Public Health Index. https://prismmarketview.com/index/public-health/ The Public Health segment highlights the most critical health crises impacting the world’s population today - including dementia, diabetes, stroke, hypertension and heart disease - as identified by the World Health Organization (WHO). The PRISM Public Health index focuses on the...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM MarketView Insight: Is It Time to Invest in Small-Cap Stocks?

NEW YORK, NY, November 7, 2023 - As the Russell 2000 recently recorded its best week in over two years, investors are turning their attention to the potential end of the Federal Reserve’s interest rate hike cycle. This shift in sentiment has sparked a remarkable surge in previously downtrodden market segments, with the index climbing more than 7.5%. Lori Calvasina, RBC Capital Markets' Head of US Equity Strategy, believes there is still room for growth as small-cap stocks begin to benefit from...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM Emerging Clean Energy Index Highlights: Uranium Companies Outshine as Solar Demand Dips in 2023

NEW YORK, NY, November 2, 2023 - The clean energy sector has experienced a tumultuous year, with the solar industry facing a potential downturn in installation demand. Yet, amid the turbulence, not all is grim within the realm of sustainable energy. A shining beacon of resilience has been the nuclear energy segment, largely propelled by the enduring need for uranium as nuclear fuel. In 2023, uranium companies have notably outperformed their clean energy counterparts. The demand for uranium, a...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM MarketView Oil & Gas Index Update: WTI Crude Reverses Gains, Earnings Season in Full Swing

NEW YORK, NY, November 1, 2023 - PRISM MarketView, a leading provider of market insight and company news, today provides its PRISM Emerging Oil & Gas overview. US equities finished mostly higher in Wednesday afternoon trading, near best levels. The S&P 500 Energy Index closed down (0.33%) versus the S&P 500 which was up +1.05%, the XLE declined by (0.23%) and the XOP was down (0.19%). Today’s PRISM Oil & Gas Index update saw WTI crude ending down 0.7%, reversing earlier gains,...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM MARKETVIEW’S EMERGING HEALTHCARE INDEX HIGHLIGHTS LIFEMD, INC. AS ITS LARGEST YTD GAINER, UP ~226%

NEW YORK, NY, November 1, 2023 - LifeMD, Inc. is the current YTD leader in the PRISM Emerging Healthcare Index. The company has seen a ~226% increase this year and is trading at approximately $6 per share. This price falls on the higher end of its 52-week range of $1.14 – $7.40 which may indicate the potential for continued growth in a potentially shorter time frame. The company’s market cap is $227MM with a 3-month average trading volume of 500K shares. ...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM MarketView Highlights Its Spooktacular Zombie Index For Halloween

NEW YORK, NY, October 30, 2023 - Halloween is the time of year where everyone has the chance to wear a costume and enjoy some spooky activities to celebrate the season such as indulging in a pumpkin flavored treat or visiting a haunted house. If you are still uncertain about what costume to wear, we are here to guide you with some timely costume ideas. For those who are looking for some thoughtful disguises and investment insights, we will be highlighting a series of Zombie stocks that are...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis

NEW YORK, NY, October 24, 2023 - The biotech sector, known for its exponential growth potential, is currently facing highly challenging market conditions. Influences like rising inflation, geopolitical tensions, and looming economic recessions have led to a sharp decline in the sector. Consequently, many small and micro-cap biotech companies are trading at all-time lows, with several down by over 80-90% in recent years. This downturn has led to many biotech firms trading below their cash...

read more
PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

PRISM MarketView Launches Mental Health Index on World Mental Health Day

Index Highlights Innovative Companies Addressing the Unseen Challenges of Mental Disorders New York City, October 11, 2023 - In honor of World Mental Health Day, which raises awareness of mental health issues on a global scale, PRISM MarketView has introduced the Prism Emerging Mental Health Index, a proprietary index focused on pioneering stocks offering innovative treatments for mood issues, anxiety, personality disorders and more....

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850

Translate »